RIPK3 and neoplasm: The overall percentage of dead wild-type ECs (either early apoptotic or late apoptotic/necrotic cells) increased by 1–3% with the increasing amount of tumor cells, whereas Ripk3−/− or Mlkl−/− ECs only showed an increase in 1–2% dead cells upon 9 × 104 tumor cell addition.